NCR1 and melanoma: The number of activated NK cells (NKp46+ and CD69+) in melanoma was elevated equally in groups of mice receiving cGAMP alone or in combination with RGD-(KLAKLAK)2 and was 2-times higher when compared with control group (Fig. 4B).